Johnson & Johnson Asks FDA To Approve Booster Shot
Johnson & Johnson has officially asked the Food and Drug Administration to approve its COVID-19 booster shot.
The company hasn’t asked for a specific time interval to administer the booster.
Instead, they submitted data sets that showed immunity against the virus went up to 94% when a second shot of their vaccine was administered two months after the first dose.
Johnson & Johnson says even without a booster, their vaccine’s protection remains stable over time.
That’s in contrast with Pfizer, which says their vaccine efficacy wanes over time.
The FDA has already approved a booster shot from Pfizer, but only for people 65 and older or those at high risk.
The FDA says it will consider boosters from Johnson & Johnson as well as Moderna at the end of next week.